PANK2 Mutation Screening Recommended to Confirm Diagnosis of Pantothenate Kinase–Associated Neurodegeneration

Samankaltaisia teoksia

• PANK activators for the treatment of pantothenate kinase-associated neurodegeneration
  Tekijä: Jessica Regan, Ph.D., et al.
  Julkaistu: (2025-07-01)
• Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration
  Tekijä: Kruer, Michael C., et al.
  Julkaistu: (2011)
• Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase–Associated Neurodegeneration
  Tekijä: Lee, J.-H., et al.
  Julkaistu: (2018)
• Novel Compound Heterozygous Mutations in the PANK2 Gene in a Chinese Patient With Atypical Pantothenate Kinase-Associated Neurodegeneration
  Tekijä: Zhang, Yu-hu, et al.
  Julkaistu: (2005)
• A Novel Nonsense Mutation in PANK2 Gene in Two Patients with Pantothenate Kinase-Associated Neurodegeneration
  Tekijä: Ghafouri-Fard, Soudeh, et al.
  Julkaistu: (2016)